Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III
Developmental Medicine & Child Neurology · 2026
DOI: 10.1111/dmcn.70031 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Developmental Medicine & Child Neurology, 2026. Verfasst von Darcy Fehlings und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Faculty of Medicine, University of Toronto, …. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Cerebral Palsy, Neuromuscular Agents, Lower Extremity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institute of Health Research, Institute of Human Development, Child and Youth Health, Institute of Human Development, Child and Youth Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To evaluate the effectiveness of repeated botulinum neurotoxin A (BoNT‐A) injections on gross motor function over 3 years in ambulant children with spastic cerebral palsy (CP).
Method
A prospective observational cohort study of 124 participants was conducted comparing outcomes in children (aged 2–6 years) with spastic CP functioning in Gross Motor Function Classification System (GMFCS) levels I to III who did and did not receive BoNT‐A. The primary outcome was the 66‐item Gross Motor Function Measure (GMFM‐66), assessed at baseline and annually over 3 years. Secondary outcomes included passive ankle dorsiflexion with knee extended (PADKE) and several measures of activity and participation.
Results
A total of 117 participants (94%), consisting of 61 cases and 56 comparisons, were assessed on the GMFM‐66 at a follow‐up of 1 year or longer, with 106 (85%) assessed at year 3. There were no significant differences in mean GMFM‐66 scores adjusted for baseline differences between groups over time ( β̂ group = 0.92, standard error [SE] = 0.81, 95% confidence interval [CI] = − 0.66 to 2.50; p = 0.256). A difference in PADKE favouring the comparison group was observed ( β̂ group = − 4.17, SE = 1.58, 95% CI = − 7.27 to − 1.08; p = 0.009), approaching the 5° minimally important difference.
Interpretation
Repeated BoNT‐A injections over 3 years were not associated with improvements in gross motor function or passive ankle dorsiflexion range in young children with spastic CP functioning in GMFCS levels I to III compared to a comparison group not receiving BoNT‐A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
- Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada.
- Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamiton, ON, Canada.
- Department of Surgery, University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada.
- CanChild Centre for Childhood-Onset Disability, Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
- Department of Physical Therapy, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Darcy Fehlings, Emma Bohn, Unni Narayanan, Peter L Rosenbaum, F Virginia Wright
Förderung
- Canadian Institute of Health Research, Institute of Human Development, Child and Youth Health
- Institute of Human Development, Child and Youth Health
Zitieren
APA
Fehlings, D., Bohn, E., Switzer, L., Goldsmith, C. H., Narayanan, U., Rosenbaum, P. L., Wright, F. V., Foster, G., & CP‐BoNT‐A Study Group (2026). Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70031
Vancouver
Fehlings D, Bohn E, Switzer L, Goldsmith CH, Narayanan U, Rosenbaum PL, et al. Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70031
BibTeX
@article{Fehlings2026,
author = {Fehlings, Darcy and Bohn, Emma and Switzer, Lauren and Goldsmith, Charles H and Narayanan, Unni and Rosenbaum, Peter L and Wright, F Virginia and Foster, Gary and CP‐BoNT‐A Study Group, CP‐BoNT‐A Study Group},
title = {Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.70031}
}
EUVIMED